SiTime Corporation vs Sanofi SA — how do they compare? SiTime Corporation trades at $598.54 (market cap $16.63B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 6.3× SiTime Corporation's market cap, and Sanofi SA pays a 5.5% dividend while SiTime Corporation pays none. Which is the better fit depends on your goals.
| SITM | SNY | |
|---|---|---|
Market Cap | $16.63B | $104.83B |
Sector | Technology | Health |
52-Week High | $901.60 | $52.34 |
52-Week Low | $190.16 | $41.33 |
Enterprise Value | $15.84B | $121.32B |
Dividend Yield | — | 5.5% |
Trailing returns across standard periods
Latest headlines on both assets
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →